Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
International Review of Neurobiology|November 25, 2010
Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's diseaseSeppo KaakkolaDuodecim; Laaketieteellinen Aikakauskirja|September 28, 2013
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties]Seppo Kaakkola, Raimo TuominenJournal of Parkinson'S Disease|April 18, 2015
Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?Filip Scheperjans, Eero Pekkonen, Seppo Kaakkola, et al.Medical Problems of Performing Artists|December 13, 2017
Musculoskeletal Symptoms Among Finnish Professional Orchestra MusiciansKatriina Viljamaa, Juha Liira, Seppo Kaakkola, et al.Neuroimage|June 1, 2005
Cholinergic modulation of preattentive auditory processing in agingEero Pekkonen, Iiro P Jääskeläinen, Seppo Kaakkola, et al.Neuroreport|September 23, 2003
Effects of an acute D2-dopaminergic blockade on the somatosensory cortical responses in healthy humans: evidence from evoked magnetic fieldsJuha Huttunen, Seppo Kähkönen, Seppo Kaakkola, et al.Brain : a Journal of Neurology|March 2, 2002
Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopaStephan Salenius, Sari Avikainen, Seppo Kaakkola, et al.Neuroimage|January 5, 2002
Aging and cholinergic modulation of the transient magnetic 40-Hz auditory responseJyrki Ahveninen, Iiro P Jääskeläinen, Seppo Kaakkola, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 23, 2003
Effects of scopolamine on MEG spectral power and coherence in elderly subjectsDaria Osipova, Jyrki Ahveninen, Seppo Kaakkola, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 14, 2005
The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in ratsSanna Janhunen, Paula Mielikäinen, Päivi Paldánius, et al.Pageof 2